These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 8964595)
21. Transforming growth factor beta and CD25 are important for controlling systemic dissemination following Yersinia enterocolitica infection of the gut. Zhong Y; Cantwell A; Dube PH Infect Immun; 2010 Sep; 78(9):3716-25. PubMed ID: 20584975 [TBL] [Abstract][Full Text] [Related]
22. Characterization of oral Yersinia enterocolitica infection in three different strains of inbred mice. Handley SA; Dube PH; Revell PA; Miller VL Infect Immun; 2004 Mar; 72(3):1645-56. PubMed ID: 14977972 [TBL] [Abstract][Full Text] [Related]
23. Protective role of interleukin-6 during Yersinia enterocolitica infection is mediated through the modulation of inflammatory cytokines. Dube PH; Handley SA; Lewis J; Miller VL Infect Immun; 2004 Jun; 72(6):3561-70. PubMed ID: 15155665 [TBL] [Abstract][Full Text] [Related]
24. Comparison of the cytokine immune response to pathogenic Yersinia enterocolitica bioserotype 1B/O:8 and 2/O:9 in susceptible BALB/C and resistant C57BL/6 mice. Wang X; Gu W; Qiu H; Xia S; Zheng H; Xiao Y; Liang J; Jing H Mol Immunol; 2013 Oct; 55(3-4):365-71. PubMed ID: 23582306 [TBL] [Abstract][Full Text] [Related]
25. Desferrioxamine-promoted virulence of Yersinia enterocolitica in mice depends on both desferrioxamine type and mouse strain. Autenrieth IB; Reissbrodt R; Saken E; Berner R; Vogel U; Rabsch W; Heesemann J J Infect Dis; 1994 Mar; 169(3):562-7. PubMed ID: 8158027 [TBL] [Abstract][Full Text] [Related]
26. Involvement of the virulence gene products of Yersinia enterocolitica in the immune response of infected mice. Takeuchi O; Suzuki T; Kawamura I; Kobayashi N; Takizawa-Hashimoto A; Mitsuyama M FEMS Immunol Med Microbiol; 2005 Aug; 45(2):321-9. PubMed ID: 16019194 [TBL] [Abstract][Full Text] [Related]
28. Yersinia enterocolitica ghost with msbB mutation provides protection and reduces proinflammatory cytokines in mice. Cai K; Zhang Y; Yang B; Chen S Vaccine; 2013 Jan; 31(2):334-40. PubMed ID: 23153438 [TBL] [Abstract][Full Text] [Related]
29. Murine neonates are highly resistant to Yersinia enterocolitica following orogastric exposure. Echeverry A; Schesser K; Adkins B Infect Immun; 2007 May; 75(5):2234-43. PubMed ID: 17325052 [TBL] [Abstract][Full Text] [Related]
30. Yersinia enterocolitica YopH-Deficient Strain Activates Neutrophil Recruitment to Peyer's Patches and Promotes Clearance of the Virulent Strain. Dave MN; Silva JE; Eliçabe RJ; Jeréz MB; Filippa VP; Gorlino CV; Autenrieth S; Autenrieth IB; Di Genaro MS Infect Immun; 2016 Nov; 84(11):3172-3181. PubMed ID: 27550935 [TBL] [Abstract][Full Text] [Related]
31. Increased susceptibility to Yersinia enterocolitica Infection of Tff2 deficient mice. Shah AA; Mihalj M; Ratkay I; Lubka-Pathak M; Balogh P; Klingel K; Bohn E; Blin N; Baus-Loncar M Cell Physiol Biochem; 2012; 30(4):853-62. PubMed ID: 22907484 [TBL] [Abstract][Full Text] [Related]
32. Humoral and cellular immune reaction in Balb/c mice infected with Yersinia enterocolitica. Zaremba M; Kacprzak-Wiatr A Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):619-23. PubMed ID: 749815 [TBL] [Abstract][Full Text] [Related]
33. Characterization of the synovial T cell response to various recombinant Yersinia antigens in Yersinia enterocolitica-triggered reactive arthritis. Heat-shock protein 60 drives a major immune response. Mertz AK; Ugrinovic S; Lauster R; Wu P; Grolms M; Böttcher U; Appel H; Yin Z; Schiltz E; Batsford S; Schauer-Petrowski C; Braun J; Distler A; Sieper J Arthritis Rheum; 1998 Feb; 41(2):315-26. PubMed ID: 9485090 [TBL] [Abstract][Full Text] [Related]
34. DNA immunization confers systemic, but not mucosal, protection against enteroinvasive bacteria. Noll A; Bücheler N; Bohn E; Schirmbeck R; Reimann J; Autenrieth IB Eur J Immunol; 1999 Mar; 29(3):986-96. PubMed ID: 10092103 [TBL] [Abstract][Full Text] [Related]
35. A role for IL-1 alpha in inducing pathologic inflammation during bacterial infection. Dube PH; Revell PA; Chaplin DD; Lorenz RG; Miller VL Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10880-5. PubMed ID: 11526216 [TBL] [Abstract][Full Text] [Related]
36. In vivo tracking and protective properties of Yersinia-specific intestinal T cells. Kempf VA; Bohn E; Noll A; Bielfeldt C; Autenrieth IB Clin Exp Immunol; 1998 Sep; 113(3):429-37. PubMed ID: 9737673 [TBL] [Abstract][Full Text] [Related]
37. Effects of Yersinia enterocolitica O:3 derivatives on B lymphocyte activation in vivo. Crespo Ade M; Falcão DP; Ferreira de Araújo PM; Machado de Medeiros BM Microbiol Immunol; 2002; 46(2):95-100. PubMed ID: 11939584 [TBL] [Abstract][Full Text] [Related]
38. Plasmid associated antibody production against Yersinia enterocolitica in man. Skurnik M; Nurmi T; Granfors K; Koskela M; Tiilikainen AS Scand J Infect Dis; 1983; 15(2):173-7. PubMed ID: 6879115 [TBL] [Abstract][Full Text] [Related]
39. Conjugation of hydroxyethyl starch to desferrioxamine (DFO) modulates the dual role of DFO in Yersinia enterocolitica infection. Schubert S; Autenrieth IB Clin Diagn Lab Immunol; 2000 May; 7(3):457-62. PubMed ID: 10799461 [TBL] [Abstract][Full Text] [Related]